Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 49
Item hits:
Issue DateTitleAuthor(s)
14-Dec-2016Endocrine therapy in epithelial ovarian cancerLangdon, SP; Gourley, C; Gabra, H; Stanley, B
29-May-2014Molecular physiology monitoring of ovarian cancer ex vivo.Fotopoulou, C; Gorgy, T; Paterson, A; Petkos, K; Cunnea, P, et al
1-Oct-2015Dose-finding quantitative F-18-FDG PET imaging study with the oral pan-AKT inhibitor GSK2141795 in patients with gynecologic malignanciesGungor, H; Saleem, A; Babar, S; Dina, R; El-Bahrawy, MA, et al
12-Jan-2016Metabonomic analysis of ovarian tumour cyst fluid by proton nuclear magnetic resonance spectroscopyKyriakides, M; Rama, N; Sidhu, J; Gabra, H; Keun, HC, et al
31-Jul-2015Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinomaMatsuo, K; Hasegawa, K; Yoshino, K; Murakami, R; Hisamatsu, T, et al
2-Oct-2017A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer.Kreuzinger, C; Geroldinger, A; Smeets, D; Braicu, EI; Sehouli, J, et al
19-Oct-2015A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathwayCheraghchi-Bashi, A; Parker, CA; Curry, E; Salazar, J-F; Gungor, H, et al
7-Jul-2016Integrative analysis of subcellular quantitative proteomics studies reveals functional cytoskeleton membrane–lipid raft interactions in cancerShah, AD; Inder, KL; Shah, AK; Cristino, AS; McKie, AB, et al
2-Oct-2018Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studyBlagden, SP; Rizzuto, I; Suppiah, P; O'Shea, D; Patel, M, et al
30-Jun-2011Integrated genomic analyses of ovarian carcinomaBell, D; Berchuck, A; Birrer, M; Chien, J; Cramer, DW, et al